We align the interests of the firm with our clients and strive to deliver alpha in every aspect of our business, from generating consistent investment performance, to promoting sustainable business practices, to delivering successful long-
term outcomes.
Here you can learn more about our company, our team and careers at ClearBridge.
ClearBridge Investments has been recognized by Pensions & Investments Magazine as a "Best Place to Work in Money Management" in all nine years of the survey.
These awards reflect the Firm's spirit of collaboration, work/life balance and ongoing investment in our employees.
Emerging Markets 4Q25: The Strategy outperformed the benchmark for the quarter and full year, led by strong contributions from our holdings in Korea, China and Taiwan.
Large Cap Growth ESG 4Q25: Resurgent growth in the economy ex-tech from fiscal stimulus and easing monetary policy could lead to increased participation beyond AI such as in health care and short-cycle industrials.
Small Cap 4Q25: A challenging year for small caps ended with signs that improving earnings dynamics and attractive valuations may begin to favor patient, disciplined portfolios.
Select Strategy 4Q25: We continued to upgrade the portfolio for a volatile market environment, initiating six new common stock positions while expanding our private market exposure to innovative companies.
Global Value Improvers 4Q25: A broadening global rally and improving fundamentals across key holdings supported strong fourth-quarter performance for Global Value Improvers.
Appreciation ESG 4Q25: We have seen incremental improvements in governance goals in recent years, and they remain worthy of supportive company dialogue.
International Growth ADR 4Q25: European and U.K. banks are benefiting from a cyclical resurgence and improving earnings. We have increased exposure through our structural growth bucket.
Dividend Strategy 4Q25: With investors beginning to ask whether AI represents a bubble, our approach limits the risk of a bubble popping.
Canadian Equity Strategy 4Q25: The Strategy underperformed for the quarter due to differentiated exposure to the top heavy materials and technology sectors compared to the benchmark.
International Growth ACWI ex-US 4Q25: The Strategy saw strength in holdings supporting the buildout of AI workloads as well as several pharmaceutical makers, an improving area in health care that was a focus of activity in the quarter.
